| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 5 |
| 1 | LEVOTHYROXINE SODIUM | 4 |
| 2 | LEVOTHYROXINE SODIUM ANHYDROUS | 4 |
| 3 | LITHIUM CARBONATE | 4 |
| 4 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | 3 |
| 5 | FOLIC ACID | 3 |
| 6 | LABETALOL | 3 |
| 7 | MAGNESIUM | 3 |
| 8 | ONDANSETRON HYDROCHLORIDE | 3 |
| 9 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBUPROFEN LYSINE | 1 | 0.0018 |
| 1 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 3 | 0.0005 |
| 2 | OXYTOCIN | 1 | 0.0003 |
| 3 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | 3 | 0.0003 |
| 4 | LITHIUM CARBONATE | 4 | 0.0002 |
| 5 | LABETALOL | 3 | 0.0002 |
| 6 | ZIDOVUDINE | 2 | 0.0002 |
| 7 | LOPINAVIR AND RITONAVIR | 2 | 0.0001 |
| 8 | CLOZAPINE | 5 | 0.0000 |
| 9 | LEVOTHYROXINE SODIUM ANHYDROUS | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 5 |
| 1 | Barbiturate [EPC] | 3 |
| 2 | Central Nervous System Stimulant [EPC] | 3 |
| 3 | Methylxanthine [EPC] | 3 |
| 4 | Serotonin-3 Receptor Antagonist [EPC] | 3 |
| 5 | Vitamin B12 [EPC] | 3 |
| 6 | Vitamin C [EPC] | 3 |
| 7 | Vitamin D [EPC] | 3 |
| 8 | beta-Adrenergic Blocker [EPC] | 3 |
| 9 | Complement Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 1 | 0.0003 |
| 1 | Barbiturate [EPC] | 3 | 0.0003 |
| 2 | Methylxanthine [EPC] | 3 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Central Nervous System Stimulant [EPC] | 3 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 5 | 0.0000 |